[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Verrill et al., 1977 - Google Patents

Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.

Verrill et al., 1977

View PDF
Document ID
951554442624286275
Author
Verrill H
Pickard N
Gruemer H
Publication year
Publication venue
Clinical chemistry

External Links

Snippet

Above-normal plasma enzyme activities resulting from increased release of intracellular macromolecules are an important diagnostic feature of Duchenne muscular dystrophy. These and other biochemical and histological characteristics of this disease are faithfully …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
CA1199883A (en) Assessment of nutritional status of individuals
Greaves et al. Immunosuppressive potency and in-vitro activity of antilymphocyte globulin
Mowat et al. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis
Cohen et al. Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects
Jones et al. Subcellular distribution and mobilization of MAC-1 (CD11b/CD18) in neonatal neutrophils
Eastman et al. Distinctions between idiopathic ineffective erythropoiesis and di Guglielmo’s disease: clinical and biochemical differences
MX2007007326A (en) Suspension medium for red blood cells.
Rieder et al. Hemoglobin Zürich: clinical, chemical and kinetic studies
Scott et al. Erythropoietic protoporphyria with features of a sideroblastic anaemia terminating in liver failure
Gavin et al. Evidence that iron stores regulate iron absorption—a setpoint theory
Anderson et al. Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients
ELSAS et al. Wilson's Disease with reversible renal tubular dysfunction: Correlation with proximal tubular ultrastructure
Verrill et al. Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.
Lewis et al. Hypercupremia associated with a monoclonal immunoglobulin
McMillan et al. Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura
AGGERBECK et al. Hypobetalipoproteinemia: Clinical and biochemical description of a new kindred with ‘Friedreich” s ataxia'
Hakala et al. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract
Lind et al. Observations on blood glucose and insulin determinations
FROELICH et al. A case of Guillain-Barre syndrome with immunologic abnormalities
Werre et al. Causes of macroplania of erythrocytes in diseases of the liver and biliary tract with special reference to leptocytosis
White et al. Platelet spherocytosis: a new bleeding disorder
Nakashima et al. Red cell density in various blood disorders
Rokkones et al. Congenital renal dysplasia, retinal dysplasia and mental retardation associated with hyperprolinuria and hyper‐OH‐prolinuria
Lane et al. Defective energy metabolism in stored granulocytes
Kantor et al. Cytomegalovirus infection associated with cardiopulmonary bypass